Philips files its robotic surgery patents with a deliberate international reach, with well-constructed claims extending protection across multiple markets. A high rate of FDA product clearances connects that IP coverage to actual market output. Strong research investment sits behind both, and targeted acquisition activity adds capability to a commercial profile anchored by regulatory momentum and geographic spread.